CXCL8 and neoplastic disease or syndrome: In addition to providing new insights into the regulation of osteoclastogenesis and signaling events involved in this process, we identified cytokines, in particularly IL-8, as potential therapeutic target for inhibition of osteoclast formation and function in rheumatoid and in neoplastic disorders, with a possible novel mechanism from existing RANKL inhibition therapies.